Mechanisms of hypersensitivity in IBS and functional disorders (Q36728934)

15 August 2017

1 reference

title

Mechanisms of hypersensitivity in IBS and functional disorders (English)

1 reference

15 August 2017

7

R C Spiller

1 reference

15 August 2017

F Azpiroz

1

1 reference

15 August 2017

M Bouin

2

1 reference

15 August 2017

M Camilleri

3

1 reference

15 August 2017

E A Mayer

4

1 reference

15 August 2017

P Poitras

5

1 reference

15 August 2017

J Serra

6

1 reference

15 August 2017

publication date

1 January 2007

1 reference

Neurogastroenterology and Motility

15 August 2017

published in

1 reference

15 August 2017

volume

19

1 reference

15 August 2017

issue

1 Suppl

1 reference

15 August 2017

page(s)

62-88

1 reference

Altered rectal perception is a biological marker of patients with irritable bowel syndrome.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Tolerance to gastric distension in patients with functional dyspepsia: modulation by a cholinergic and nitrergic method

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Intrarectal injection of glycerol induces hypersensitivity to rectal distension in healthy subjects without modifying rectal compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome (IBS) patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Exaggerated motility of the descending colon with repetitive distention of the sigmoid colon in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Evolution of visceral sensitivity in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Group counseling psychotherapy for patients with functional gastrointestinal disorders: development of new measures for symptom severity and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Clinical characteristics and natural history of symptomatic but not excess gastroesophageal reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Tegaserod is safe, well tolerated and effective in the treatment of patients with non-diarrhoea irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Is rectal pain sensitivity a biological marker for irritable bowel syndrome: psychological influences on pain perception

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

A systematic review of neuroimaging data during visceral stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Human brain mechanisms of pain perception and regulation in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Psychological and neural mechanisms of the affective dimension of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Central representation of visceral and cutaneous hypersensitivity in the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Bad news from the brain: descending 5-HT pathways that control spinal pain processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Chronic pain and medullary descending facilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Nociceptive processing in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Regional mu opioid receptor regulation of sensory and affective dimensions of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Importance of anti- and pro-nociceptive mechanisms in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

The effect of negative emotional context on neural and behavioural responses to oesophageal stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Cognitive modulation of the cerebral processing of human oesophageal sensation using functional magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Brain functional magnetic resonance imaging of rectal pain and activation of endogenous inhibitory mechanisms in irritable bowel syndrome patient subgroups and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Sex-based differences in gastrointestinal pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Longitudinal change in perceptual and brain activation response to visceral stimuli in irritable bowel syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Multimodal pain stimulations in patients with grade B oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Increased capsaicin receptor TRPV1 nerve fibres in the inflamed human oesophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Immune-mediated neural dysfunction in a murine model of chronic Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Intestinal inflammation and activation of sensory nerve pathways: a functional and morphological study in the nematode infected rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Distribution of calcitonin gene-related peptide, somatostatin, substance P and vasoactive intestinal polypeptide in experimental colitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Perceptual responses in patients with inflammatory and functional bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Alteration of the spinal modulation of nociceptive processing in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Patterns of pain in diverticular disease and the influence of acute diverticulitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Colorectal visceral perception in diverticular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Gastrointestinal gas following food consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Follow-up of a flatulent patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Physiological basis of gas exchange in the gut

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Aerophagia, gastric, and supragastric belching: a study using intraluminal electrical impedance monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Intestinal gas distribution determines abdominal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Gastric distension and duodenal lipid infusion modulate intestinal gas transit and tolerance in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Duodenal infusion of different nutrients and the site of gaseous stimulation influence intestinal gas dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Sites of symptomatic gas retention during intestinal lipid perfusion in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Influence of body posture on intestinal transit of gas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Prokinetic effects in patients with intestinal gas retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Origin of gas retention and symptoms in patients with bloating

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Impaired small bowel gas propulsion in patients with bloating during intestinal lipid infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Impaired reflex control of intestinal gas transit in patients with abdominal bloating

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Abnormal colonic fermentation in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

A comparison of symptoms after the consumption of milk or lactose-hydrolyzed milk by people with self-reported severe lactose intolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Impaired viscerosomatic reflexes and abdominal-wall dystony associated with bloating

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Serotonin transporter gene polymorphism in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Is there a SERT-ain association with IBS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Familial aggregation of irritable bowel syndrome: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2006.00875.X

10.1111/J.1365-2982.2006.00875.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference